Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Filippo Lococo
Observed names:
F. Lococo,
Lococo, F
Institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0009-0002-2462-1613
Observed ORCID:
0009-0002-2462-1613
OpenAlex ID:
A5076253658
Eradicating Drug-tolerant Persister Cells in EGFR- Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
·
Cancer Discovery
·
44
Lymph Node Involvement and Radiologic Predictors of Invasiveness in Pure Ground-Glass Adenocarcinomas: The GORDON Study
2025
·
Chiara Catelli
, Susanna Guerrini
, et al.
·
The Annals of Thoracic Surgery
·
9
Immune Checkpoint Inhibitors in Malignant Pleural Mesothelioma: Efficacy, Real-World Outcomes, and the Search for Predictive Biomarkers
2026
·
Giusi Bondì
, Serafina Martella
, et al.
·
Current Oncology
·
2
PDF
Imatinib-Associated Interstitial Lung Disease with a Fibrotic NSIP Pattern on Transbronchial Lung Cryobiopsy: A Case Report and Review of the Literature
2026
·
Pier-Valerio Mari
, Lorenzo Carriera
, et al.
·
Reports — Medical Cases Images and Videos
·
1
Management of Hemothorax After Blunt Chest Trauma: Results from a Level II Emergency Department
2026
·
Dania Nachira
, Antonio Giulio Napolitano
, et al.
·
Journal of Clinical Medicine
·
1
PDF
248P LANTERN2: Inter-relationship between PDL1 expression, IASLC histological pattern and tumor stage in a perspective real world NSCLC population
2026
·
C. Sassorossi
, A. Cancellieri
, et al.
·
ESMO Open
Data from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
Figure S2 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S11 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S5 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S4 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S1 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S3 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S10 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
Figure S6 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S7 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S8 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Figure S9 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
PDF
Table S1 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
Table S2 from Eradicating Drug-tolerant Persister Cells in EGFR-Mutated Non–Small Cell Lung Cancer by Targeting TROP2 with CAR-T Cellular Therapy
2025
·
Simon Baldacci
, Elliott J. Brea
, et al.
P-83 The impact of the multidisciplinary team (MDT) in the management of colorectal cancer (CRC)
2022
·
F. Schietroma
, M. Bensi
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
22
Citation count:
57
H-index:
2
I10-index:
1
Year
Topic
Type